Tremendous Potential for Fibromyalgia Pharmaceuticals in Europe
With no available therapy for the treatment of fibromyalgia syndrome (FS), pharmaceutical companies have shown great interest in coming up with possible recommendations and therapies for treatment. Central nervous system (CNS) niche disorders have always been a major challenge and FS is no different. Some of the key products in late-stage clinical trials have shown considerable promise and offer high growth opportunities.
FDA Clears the DPL (Deep Penetrating Light) Therapy System for Over-the-Counter – Home Use
LED Technologies, LLC announced today that the U.S. Food and Drug Administration (FDA) cleared their DPL Therapy System for the relaxation of muscles and relief of muscle spasms, temporary relief of minor muscle and joint aches, pains and stiffness; temporary relief of minor pain and stiffness associated with arthritis; and to temporarily increase local blood circulation. This clearance launches the way for the DPL Therapy System to bring temporary pain relief technology directly to the consumer without a prescription.
Irritable Bowel Syndrome
As the name suggests, IBS is a disorder which affects the lower digestive tract. The contents of the bowel are moved along by a rhythmic tightening and relaxation of the muscles of the intestinal wall – a process called peristalsis.
Old treatments effective for irritable bowel syndrome
Those older treatments that used to be used for irritable bowel syndrome may end up being the best option for patients. A new study finds fiber, anti-spasmodic drugs and peppermint oil were all found to be effective in a review of the evidence. As a result, researchers in the British Medical Journal say guidelines on IBS should be updated in light of the findings.